Type: dissertation
Abstract: Transferrin receptor 2 (Tfr2) is an iron-modulator transcribed in two isoforms, Tfr2a and Tfr2b.The latter is expressed in the heart.We obtained two mouse models with silencing of Tfr2b: one with a normal systemic iron amount (SIA), i.e., Tfr2-KI, and the other, i.e., LCKO-KI, with high SIA due to hepatic Tfr2a silencing.We aimed to assess whether Tfr2b might play a role in myocardial injury and whether Tfr2b silencing might modify proteins of iron metabolism, antioxidant, apoptotic, and survival enzyme activities in the heart undergoing ischemia/reperfusion (I/R).Isolated hearts of wild-type (WT) and Tfr2-null mice were studied before or after an I/R protocol, and proteins/RNA analyzed by Western blot and/or quantitative PCR.Tfr2b increased in WT hearts subject to I/R, and both Tfr2b null mice hearts were protected against I/R injury (about 40% smaller infarct-size compared to WT hearts).RISK kinases
Author: BOERO, MARTINA
Institution: University of Turin
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G3504711979, G8219297896
OpenAlex ID: W7217363317
